Cargando…
Radioimmunotherapy Improves Survival of Rats with Microscopic Liver Metastases of Colorectal Origin
BACKGROUND: Half of the patients with colorectal cancer develop liver metastases during the course of their disease. The aim of the present study was to assess the efficacy of radioimmunotherapy (RIT) with a radiolabeled monoclonal antibody (mAb) to treat experimental colorectal liver metastases. ME...
Autores principales: | de Jong, Gabie M., Hendriks, Thijs, Eek, Annemarie, Oyen, Wim J. G., Heskamp, Sandra, Bleichrodt, Robert P., Boerman, Otto C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695874/ https://www.ncbi.nlm.nih.gov/pubmed/19430843 http://dx.doi.org/10.1245/s10434-009-0477-6 |
Ejemplares similares
-
A Comparison Between Radioimmunotherapy and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis of Colonic Origin in Rats
por: Aarts, F., et al.
Publicado: (2007) -
Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry
por: van de Watering, Floor C. J., et al.
Publicado: (2014) -
Tumor-Associated Antigen Expressing Listeria monocytogenes Induces Effective Primary and Memory T-Cell Responses Against Hepatic Colorectal Cancer Metastases
por: Olino, Kelly, et al.
Publicado: (2011) -
Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases
por: Enblad, Malin, et al.
Publicado: (2019) -
Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides
por: Vegt, Erik, et al.
Publicado: (2009)